December 13, 2022
December 13, 2022
Categories

Press Release: Practice-changing trial results for acute lymphoblastic leukemia (ALL)

Do you like it?
Read more
December 11, 2022
December 11, 2022
Categories

Press Release: A unique clinical trial leads to a dramatic decrease in early deaths from the rare and aggressiveā€”yet highly curableā€”acute promyelocytic leukemia (APL)

Do you like it?
Read more
December 6, 2022
December 6, 2022
Categories

Press Release: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes

Do you like it?
Read more
October 28, 2022
October 28, 2022
Categories

Press Release: NCI Director Monica Bertagnolli delivers her first public speech at the ECOG-ACRIN Cancer Research Group meeting

Do you like it?
Read more
October 26, 2022
October 26, 2022
Categories

Press Release: NCI-MATCH cancer trial finds a promising signal for the AKT inhibitor ipatasertib

Do you like it?
Read more
October 21, 2022
October 21, 2022
Categories

Press Release: Head and neck cancer researchers demonstrate the capability of a deep learning algorithm in the post-surgery setting to assess the stage of disease more accurately using standard CT scans

Do you like it?
Read more
October 13, 2022
October 13, 2022
Categories

The September/October 2022 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
October 4, 2022
October 4, 2022
Categories

DREAMseq trial clarifies immunotherapy, targeted treatment order for patients with BRAF-mutant metastatic melanoma

Do you like it?
Read more
September 30, 2022
September 30, 2022
Categories

Advanced melanoma survival improves significantly when immunotherapy is given before targeted therapy

Do you like it?
Read more
Load more
ECOG-ACRIN Cancer Research Group